27 October 2020
\n \n \n \nCongratulations are in order for Associate Professor Samira Lakhal-Littleton, who has been awarded a Senior Non-Clinical Fellowship by the Medical Research Council to further her lab's work exploring the implications of the cardiac hepcidin/ferroportin axis for the management of iron deficiency in heart failure.
\n \n\n \n \n19 October 2020
\n \n \n \n\n \n \n11 October 2020
\n \n \n \nProfessor Paul Riley will lead the scientific vision of the first institute of its kind in the world to physically merge the disciplines of developmental biology and regenerative medicine in a common goal to treat some of the world\u2019s most prolific diseases.
\n \n\n \n \n4 September 2020
\n \n \n \nThe partnership will produce the first ever British Society of Echocardiography National review of Stress Echocardiography Practice (BSE N-STEP).
\n \n\n \n \n4 September 2020
\n \n \n \nA new paper from the Heather and Tyler groups has uncovered the mechanism responsible for reduced energy in the hearts of patients with type 2 diabetes and revealed a new therapeutic strategy to reverse the energy deficit.
\n \n\n \n \n15 July 2020
\n \n \n \nThe number of admissions to hospital with heart attacks fell by 35% by the end of March.
\n \n\n \n \n14 July 2020
\n \n \n \n\n \n \n13 July 2020
\n \n \n \n\n \n \n8 July 2020
\n \n \n \n\n \n \n26 May 2020
\n \n \n \nDPAG researchers have collaborated on an international study that demonstrates a detailed mechanistic understanding of how the anti-malaria drug, Hydroxychloroquine, combined with antibiotics, can cause adverse cardiac side-effects in COVID-19 patients. This gives weight to US Federal advice against using this combined treatment.
\n \n\n \n \n14 May 2020
\n \n \n \n\n \n \n27 April 2020
\n \n \n \nNew collaborative research from the Mommersteeg Group and MRC WIMM researchers shows that a protein called Runx1 plays a significant role in the formation of the cardiac scar that forms after the heart is injured, a scar that is known to inhibit heart regeneration. In the zebrafish, a freshwater fish known to be able to fully regenerate its heart after damage, they show that the absence of Runx1 results in enhanced regeneration. This indicates a potential new therapeutic target for heart repair.
\n \n\n \n \n27 January 2020
\n \n \n \n\n \n \n23 January 2020
\n \n \n \n\n \n \n14 January 2020
\n \n \n \nUp to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease \u2013 a leading cause of death in the UK.
\n \n\n \n \n8 January 2020
\n \n \n \nFor many years, we have been using beta-blockers to neutralise a specific stress hormone and prevent dangerous heart rhythms following a heart attack. However, a new study led by Associate Professor Neil Herring and published in the European Heart Journal has uncovered evidence for an additional stress hormone acting as a key trigger for dangerous heart rhythms that is not currently targeted by these drugs.
\n \n\n \n \n3 December 2019
\n \n \n \n\n \n \n21 October 2019
\n \n \n \nCongratulations are in order to Professor Manuela Zaccolo on being elected Fellow of the Royal Society of Biology.
\n \n\n \n \n22 July 2019
\n \n \n \nA collaborative paper from the De Val and Smart Groups has established multiple regulatory pathways responsible for the formation of blood vessels in the developing heart. In doing so they have identified a crucial pathway that is repressed in the adult heart after injury, which may hold the key to a new and improved strategy for repair.
\n \n\n \n \n16 July 2019
\n \n \n \nDecoding the pharmacological goldmine in tick saliva.
\n \n\n \n \n